On The Front Lines

Everyday The Rutherford Institute is waging a battle to protect the human rights and civil liberties of all people. Whether challenging undue government suppression of civil liberties in the courts or calling upon political leaders to strengthen their commitment to universal moral values, The Rutherford Institute works tirelessly to maintain the rights enshrined in the Constitution, and regain those that have been lost to government intrusion.

On the Front Lines (Rutherford Press Alerts) will keep you abreast of the most recent actions The Rutherford Institute has undertaken in its fight for human rights and civil liberties. From pending litigation to victories for human rights and civil liberties, On the Front Lines is the place to find information on the most pressing issues of the day. The Rutherford Institute is waging for our rights in the courts and beyond. On The Front Lines will keep you up-to-date on the crucial battles

Recent Articles

April 29, 2021

Challenging Technocensorship: Rutherford Institute Asks Court To Prohibit Facebook From Censoring, De-Platforming COVID-19 Vaccine Critics

Warning against the rising threat to free speech posed by the government’s collusion with large technology companies in order to regulate and control what ideas can be shared on the internet and through social media, The Rutherford Institute has asked a federal court to prohibit Facebook from censoring and de-platforming critics of the COVID-19 vaccine in violation of the First Amendment.

April 26, 2021

Rutherford Institute Challenges Government Overreach, Compelled Speech & Efforts To Boost State Budgets Through Fines & Penalties

Weighing in on a case before the U.S. Supreme Court, The Rutherford Institute is challenging government overreach, compelled speech and attempts to boost state budgets through fines and penalties. In an amicus brief filed with the Cato Institute in Bristol-Myers Squibb Co. v. Connors, attorneys argue that the government’s attempts to impose millions of dollars in penalties on a drug manufacturer for failing to adopt and espouse the government’s position on controversial scientific matter constitutes compelled speech in violation of the First Amendment.